학술논문

Metabolomic data presents challenges for epidemiological meta-analysis: a case study of childhood body mass index from the ECHO consortium
Document Type
article
Source
Metabolomics. 20(1)
Subject
Medical Biochemistry and Metabolomics
Reproductive Medicine
Biomedical and Clinical Sciences
Pediatric
Clinical Research
Child
Female
Pregnancy
Humans
Child
Preschool
Body Mass Index
Reproducibility of Results
Metabolomics
Linear Models
Lysine
Childhood obesity
Maternal metabolites
Metabolomic epidemiology
Metabolomic meta-analysis
Analytical Chemistry
Biochemistry and Cell Biology
Clinical Sciences
Biochemistry and cell biology
Medical biochemistry and metabolomics
Analytical chemistry
Language
Abstract
IntroductionMeta-analyses across diverse independent studies provide improved confidence in results. However, within the context of metabolomic epidemiology, meta-analysis investigations are complicated by differences in study design, data acquisition, and other factors that may impact reproducibility.ObjectiveThe objective of this study was to identify maternal blood metabolites during pregnancy (> 24 gestational weeks) related to offspring body mass index (BMI) at age two years through a meta-analysis framework.MethodsWe used adjusted linear regression summary statistics from three cohorts (total N = 1012 mother-child pairs) participating in the NIH Environmental influences on Child Health Outcomes (ECHO) Program. We applied a random-effects meta-analysis framework to regression results and adjusted by false discovery rate (FDR) using the Benjamini-Hochberg procedure.ResultsOnly 20 metabolites were detected in all three cohorts, with an additional 127 metabolites detected in two of three cohorts. Of these 147, 6 maternal metabolites were nominally associated (P  100), we failed to identify significant metabolite associations after FDR correction. Our investigation demonstrates difficulties in applying epidemiological meta-analysis to clinical metabolomics, emphasizes challenges to reproducibility, and highlights the need for standardized best practices in metabolomic epidemiology.